nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—pancreatic cancer—germ cell cancer	0.525	1	CtDrD
Gemcitabine—ABCC10—Etoposide—germ cell cancer	0.082	0.336	CbGbCtD
Gemcitabine—TYMS—Methotrexate—germ cell cancer	0.0657	0.269	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—germ cell cancer	0.0542	0.222	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—germ cell cancer	0.0135	0.0554	CbGbCtD
Gemcitabine—ABCB1—Vinblastine—germ cell cancer	0.00848	0.0347	CbGbCtD
Gemcitabine—ABCB1—Cisplatin—germ cell cancer	0.00778	0.0318	CbGbCtD
Gemcitabine—ABCB1—Etoposide—germ cell cancer	0.00764	0.0313	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—germ cell cancer	0.00505	0.0207	CbGbCtD
Gemcitabine—Lamivudine—SLC22A3—germ cell cancer	0.00149	1	CrCbGaD
Gemcitabine—TYMS—Trans-sulfuration and one carbon metabolism—DNMT3L—germ cell cancer	0.00131	0.0347	CbGpPWpGaD
Gemcitabine—POLD1—Global Genomic NER (GG-NER)—ERCC4—germ cell cancer	0.00122	0.0323	CbGpPWpGaD
Gemcitabine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.0012	0.0318	CbGpPWpGaD
Gemcitabine—POLD1—neck—germ cell cancer	0.0012	0.0192	CbGeAlD
Gemcitabine—POLE—Global Genomic NER (GG-NER)—ERCC4—germ cell cancer	0.00118	0.0312	CbGpPWpGaD
Gemcitabine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00108	0.0286	CbGpPWpGaD
Gemcitabine—POLD1—Global Genomic NER (GG-NER)—ERCC1—germ cell cancer	0.00107	0.0283	CbGpPWpGaD
Gemcitabine—POLE—Global Genomic NER (GG-NER)—ERCC1—germ cell cancer	0.00103	0.0273	CbGpPWpGaD
Gemcitabine—RRM2—Vinorelbine—Vinblastine—germ cell cancer	0.000997	0.451	CbGdCrCtD
Gemcitabine—POLD1—Transcription-coupled NER (TC-NER)—ERCC4—germ cell cancer	0.000977	0.0258	CbGpPWpGaD
Gemcitabine—POLE—Transcription-coupled NER (TC-NER)—ERCC4—germ cell cancer	0.000943	0.0249	CbGpPWpGaD
Gemcitabine—POLD1—Nucleotide Excision Repair—ERCC4—germ cell cancer	0.000898	0.0237	CbGpPWpGaD
Gemcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00088	0.0233	CbGpPWpGaD
Gemcitabine—POLE—Nucleotide Excision Repair—ERCC4—germ cell cancer	0.000867	0.0229	CbGpPWpGaD
Gemcitabine—POLD1—Transcription-coupled NER (TC-NER)—ERCC1—germ cell cancer	0.000854	0.0226	CbGpPWpGaD
Gemcitabine—POLE—Transcription-coupled NER (TC-NER)—ERCC1—germ cell cancer	0.000825	0.0218	CbGpPWpGaD
Gemcitabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000819	0.0216	CbGpPWpGaD
Gemcitabine—POLD1—Nucleotide Excision Repair—ERCC1—germ cell cancer	0.000785	0.0208	CbGpPWpGaD
Gemcitabine—POLD1—skin of body—germ cell cancer	0.000775	0.0124	CbGeAlD
Gemcitabine—POLE—trigeminal ganglion—germ cell cancer	0.000773	0.0124	CbGeAlD
Gemcitabine—SLC28A1—endocrine gland—germ cell cancer	0.000769	0.0123	CbGeAlD
Gemcitabine—POLE—Nucleotide Excision Repair—ERCC1—germ cell cancer	0.000758	0.02	CbGpPWpGaD
Gemcitabine—POLE—embryo—germ cell cancer	0.000747	0.012	CbGeAlD
Gemcitabine—CMPK1—brainstem—germ cell cancer	0.00073	0.0117	CbGeAlD
Gemcitabine—CDA—decidua—germ cell cancer	0.000691	0.0111	CbGeAlD
Gemcitabine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00069	0.0183	CbGpPWpGaD
Gemcitabine—POLD1—gonad—germ cell cancer	0.000678	0.0109	CbGeAlD
Gemcitabine—POLD1—uterus—germ cell cancer	0.000673	0.0108	CbGeAlD
Gemcitabine—POLA1—trigeminal ganglion—germ cell cancer	0.000666	0.0107	CbGeAlD
Gemcitabine—CMPK1—telencephalon—germ cell cancer	0.000648	0.0104	CbGeAlD
Gemcitabine—CMPK1—skin of body—germ cell cancer	0.000618	0.00992	CbGeAlD
Gemcitabine—RRM2—embryo—germ cell cancer	0.000615	0.00987	CbGeAlD
Gemcitabine—CMPK1—decidua—germ cell cancer	0.000614	0.00985	CbGeAlD
Gemcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00061	0.0161	CbGpPWpGaD
Gemcitabine—POLD1—adrenal gland—germ cell cancer	0.000591	0.00948	CbGeAlD
Gemcitabine—POLE—decidua—germ cell cancer	0.000576	0.00923	CbGeAlD
Gemcitabine—POLA1—retina—germ cell cancer	0.000569	0.00913	CbGeAlD
Gemcitabine—POLD1—female gonad—germ cell cancer	0.000551	0.00884	CbGeAlD
Gemcitabine—CMPK1—gonad—germ cell cancer	0.000541	0.00868	CbGeAlD
Gemcitabine—CMPK1—uterus—germ cell cancer	0.000537	0.00862	CbGeAlD
Gemcitabine—CDA—adrenal gland—germ cell cancer	0.00053	0.00851	CbGeAlD
Gemcitabine—RRM1—trigeminal ganglion—germ cell cancer	0.000529	0.00849	CbGeAlD
Gemcitabine—CMPK1—pituitary gland—germ cell cancer	0.000528	0.00847	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—germ cell cancer	0.000524	0.00841	CbGeAlD
Gemcitabine—CDA—bone marrow—germ cell cancer	0.000513	0.00823	CbGeAlD
Gemcitabine—POLE—gonad—germ cell cancer	0.000507	0.00813	CbGeAlD
Gemcitabine—POLD1—head—germ cell cancer	0.000506	0.00811	CbGeAlD
Gemcitabine—SLC28A3—female gonad—germ cell cancer	0.000505	0.00811	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000503	0.0133	CbGpPWpGaD
Gemcitabine—POLA1—decidua—germ cell cancer	0.000496	0.00796	CbGeAlD
Gemcitabine—SLC29A2—adrenal gland—germ cell cancer	0.000496	0.00795	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000495	0.0131	CbGpPWpGaD
Gemcitabine—POLE—pituitary gland—germ cell cancer	0.000494	0.00793	CbGeAlD
Gemcitabine—POLD1—testis—germ cell cancer	0.000489	0.00784	CbGeAlD
Gemcitabine—RRM2—skin of body—germ cell cancer	0.000477	0.00766	CbGeAlD
Gemcitabine—RRM2—decidua—germ cell cancer	0.000474	0.0076	CbGeAlD
Gemcitabine—CMPK1—adrenal gland—germ cell cancer	0.000471	0.00756	CbGeAlD
Gemcitabine—POLD1—DNA Repair—ERCC4—germ cell cancer	0.000468	0.0124	CbGpPWpGaD
Gemcitabine—CMPK1—midbrain—germ cell cancer	0.000465	0.00747	CbGeAlD
Gemcitabine—CDA—endocrine gland—germ cell cancer	0.00046	0.00738	CbGeAlD
Gemcitabine—CMPK1—bone marrow—germ cell cancer	0.000456	0.00732	CbGeAlD
Gemcitabine—RRM1—eye—germ cell cancer	0.000456	0.00731	CbGeAlD
Gemcitabine—CMPK1—spinal cord—germ cell cancer	0.000454	0.00728	CbGeAlD
Gemcitabine—POLE—DNA Repair—ERCC4—germ cell cancer	0.000452	0.0119	CbGpPWpGaD
Gemcitabine—RRM1—retina—germ cell cancer	0.000452	0.00725	CbGeAlD
Gemcitabine—POLD1—cerebellum—germ cell cancer	0.000451	0.00724	CbGeAlD
Gemcitabine—POLE—adrenal gland—germ cell cancer	0.000442	0.00709	CbGeAlD
Gemcitabine—CMPK1—female gonad—germ cell cancer	0.00044	0.00705	CbGeAlD
Gemcitabine—CDA—testis—germ cell cancer	0.000439	0.00704	CbGeAlD
Gemcitabine—SLC29A1—trigeminal ganglion—germ cell cancer	0.00043	0.0069	CbGeAlD
Gemcitabine—SLC29A2—endocrine gland—germ cell cancer	0.00043	0.00689	CbGeAlD
Gemcitabine—POLE—bone marrow—germ cell cancer	0.000427	0.00686	CbGeAlD
Gemcitabine—POLA1—pituitary gland—germ cell cancer	0.000426	0.00684	CbGeAlD
Gemcitabine—TYMS—Vinorelbine—Vinblastine—germ cell cancer	0.000426	0.193	CbGdCrCtD
Gemcitabine—TYMS—Podofilox—Etoposide—germ cell cancer	0.000425	0.192	CbGdCrCtD
Gemcitabine—RRM2—gonad—germ cell cancer	0.000417	0.0067	CbGeAlD
Gemcitabine—RRM1—telencephalon—germ cell cancer	0.000415	0.00667	CbGeAlD
Gemcitabine—RRM2—uterus—germ cell cancer	0.000415	0.00665	CbGeAlD
Gemcitabine—POLE—female gonad—germ cell cancer	0.000412	0.00661	CbGeAlD
Gemcitabine—DCK—trigeminal ganglion—germ cell cancer	0.000411	0.00659	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00041	0.0108	CbGpPWpGaD
Gemcitabine—POLD1—DNA Repair—ERCC1—germ cell cancer	0.000409	0.0108	CbGpPWpGaD
Gemcitabine—CMPK1—endocrine gland—germ cell cancer	0.000409	0.00656	CbGeAlD
Gemcitabine—RRM2—pituitary gland—germ cell cancer	0.000407	0.00653	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000404	0.0107	CbGpPWpGaD
Gemcitabine—CMPK1—head—germ cell cancer	0.000404	0.00647	CbGeAlD
Gemcitabine—DCK—embryo—germ cell cancer	0.000397	0.00637	CbGeAlD
Gemcitabine—RRM1—skin of body—germ cell cancer	0.000396	0.00636	CbGeAlD
Gemcitabine—POLE—DNA Repair—ERCC1—germ cell cancer	0.000395	0.0104	CbGpPWpGaD
Gemcitabine—RRM1—decidua—germ cell cancer	0.000394	0.00632	CbGeAlD
Gemcitabine—ABCC10—trigeminal ganglion—germ cell cancer	0.000391	0.00628	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000391	0.0103	CbGpPWpGaD
Gemcitabine—CMPK1—testis—germ cell cancer	0.00039	0.00625	CbGeAlD
Gemcitabine—POLE—endocrine gland—germ cell cancer	0.000383	0.00615	CbGeAlD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000383	0.0101	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000381	0.0101	CbGpPWpGaD
Gemcitabine—POLA1—adrenal gland—germ cell cancer	0.000381	0.00611	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—germ cell cancer	0.000379	0.00607	CbGeAlD
Gemcitabine—POLE—head—germ cell cancer	0.000378	0.00607	CbGeAlD
Gemcitabine—TYMS—telencephalon—germ cell cancer	0.000377	0.00604	CbGeAlD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000375	0.00993	CbGpPWpGaD
Gemcitabine—POLA1—bone marrow—germ cell cancer	0.000368	0.00591	CbGeAlD
Gemcitabine—POLD1—brain—germ cell cancer	0.000367	0.00588	CbGeAlD
Gemcitabine—POLE—testis—germ cell cancer	0.000365	0.00586	CbGeAlD
Gemcitabine—TYMS—Vincristine—Vinblastine—germ cell cancer	0.000364	0.165	CbGdCrCtD
Gemcitabine—RRM2—adrenal gland—germ cell cancer	0.000364	0.00584	CbGeAlD
Gemcitabine—CMPK1—cerebellum—germ cell cancer	0.00036	0.00578	CbGeAlD
Gemcitabine—TYMS—skin of body—germ cell cancer	0.000359	0.00577	CbGeAlD
Gemcitabine—POLA1—female gonad—germ cell cancer	0.000355	0.0057	CbGeAlD
Gemcitabine—POLD1—lymph node—germ cell cancer	0.000354	0.00568	CbGeAlD
Gemcitabine—RRM2—bone marrow—germ cell cancer	0.000352	0.00565	CbGeAlD
Gemcitabine—DCK—retina—germ cell cancer	0.000351	0.00563	CbGeAlD
Gemcitabine—RRM1—gonad—germ cell cancer	0.000347	0.00556	CbGeAlD
Gemcitabine—RRM1—uterus—germ cell cancer	0.000344	0.00553	CbGeAlD
Gemcitabine—POLD1—Telomere Maintenance—H2AFZ—germ cell cancer	0.000342	0.00903	CbGpPWpGaD
Gemcitabine—RRM2—female gonad—germ cell cancer	0.000339	0.00544	CbGeAlD
Gemcitabine—RRM1—pituitary gland—germ cell cancer	0.000338	0.00543	CbGeAlD
Gemcitabine—SLC29A1—telencephalon—germ cell cancer	0.000338	0.00542	CbGeAlD
Gemcitabine—POLE—cerebellum—germ cell cancer	0.000337	0.00541	CbGeAlD
Gemcitabine—POLE—Telomere Maintenance—H2AFZ—germ cell cancer	0.00033	0.00873	CbGpPWpGaD
Gemcitabine—RRM1—medulla oblongata—germ cell cancer	0.000326	0.00524	CbGeAlD
Gemcitabine—DCK—telencephalon—germ cell cancer	0.000323	0.00518	CbGeAlD
Gemcitabine—SLC29A1—decidua—germ cell cancer	0.00032	0.00514	CbGeAlD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000318	0.00842	CbGpPWpGaD
Gemcitabine—CDA—lymph node—germ cell cancer	0.000318	0.0051	CbGeAlD
Gemcitabine—RRM2—endocrine gland—germ cell cancer	0.000315	0.00506	CbGeAlD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000315	0.00833	CbGpPWpGaD
Gemcitabine—POLA1—testis—germ cell cancer	0.000315	0.00505	CbGeAlD
Gemcitabine—TYMS—gonad—germ cell cancer	0.000314	0.00504	CbGeAlD
Gemcitabine—RRM2—head—germ cell cancer	0.000311	0.005	CbGeAlD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000311	0.00822	CbGpPWpGaD
Gemcitabine—SLC29A2—brain—germ cell cancer	0.000307	0.00493	CbGeAlD
Gemcitabine—ABCC10—telencephalon—germ cell cancer	0.000307	0.00493	CbGeAlD
Gemcitabine—DCK—decidua—germ cell cancer	0.000306	0.00491	CbGeAlD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000302	0.008	CbGpPWpGaD
Gemcitabine—RRM1—adrenal gland—germ cell cancer	0.000302	0.00485	CbGeAlD
Gemcitabine—RRM2—testis—germ cell cancer	0.000301	0.00483	CbGeAlD
Gemcitabine—RRM1—midbrain—germ cell cancer	0.000298	0.00479	CbGeAlD
Gemcitabine—SLC29A2—lymph node—germ cell cancer	0.000297	0.00477	CbGeAlD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000296	0.00783	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000294	0.00778	CbGpPWpGaD
Gemcitabine—CMPK1—brain—germ cell cancer	0.000292	0.00469	CbGeAlD
Gemcitabine—RRM1—bone marrow—germ cell cancer	0.000292	0.00469	CbGeAlD
Gemcitabine—ABCC10—decidua—germ cell cancer	0.000291	0.00468	CbGeAlD
Gemcitabine—RRM1—spinal cord—germ cell cancer	0.000291	0.00467	CbGeAlD
Gemcitabine—POLA1—cerebellum—germ cell cancer	0.000291	0.00467	CbGeAlD
Gemcitabine—POLD1—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000285	0.00753	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000284	0.00751	CbGpPWpGaD
Gemcitabine—CMPK1—lymph node—germ cell cancer	0.000283	0.00453	CbGeAlD
Gemcitabine—SLC29A1—gonad—germ cell cancer	0.000282	0.00452	CbGeAlD
Gemcitabine—RRM1—female gonad—germ cell cancer	0.000282	0.00452	CbGeAlD
Gemcitabine—SLC29A1—uterus—germ cell cancer	0.00028	0.00449	CbGeAlD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00028	0.0074	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000278	0.00736	CbGpPWpGaD
Gemcitabine—SLC29A1—pituitary gland—germ cell cancer	0.000275	0.00441	CbGeAlD
Gemcitabine—POLE—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000275	0.00727	CbGpPWpGaD
Gemcitabine—POLE—brain—germ cell cancer	0.000274	0.0044	CbGeAlD
Gemcitabine—TYMS—adrenal gland—germ cell cancer	0.000274	0.0044	CbGeAlD
Gemcitabine—TYMS—midbrain—germ cell cancer	0.000271	0.00434	CbGeAlD
Gemcitabine—DCK—gonad—germ cell cancer	0.000269	0.00432	CbGeAlD
Gemcitabine—DCK—uterus—germ cell cancer	0.000268	0.00429	CbGeAlD
Gemcitabine—TYMS—bone marrow—germ cell cancer	0.000265	0.00425	CbGeAlD
Gemcitabine—POLE—lymph node—germ cell cancer	0.000265	0.00425	CbGeAlD
Gemcitabine—DCK—pituitary gland—germ cell cancer	0.000263	0.00422	CbGeAlD
Gemcitabine—RRM1—endocrine gland—germ cell cancer	0.000262	0.0042	CbGeAlD
Gemcitabine—RRM1—head—germ cell cancer	0.000259	0.00415	CbGeAlD
Gemcitabine—ABCC10—gonad—germ cell cancer	0.000257	0.00412	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000256	0.00676	CbGpPWpGaD
Gemcitabine—TYMS—female gonad—germ cell cancer	0.000255	0.0041	CbGeAlD
Gemcitabine—ABCC10—uterus—germ cell cancer	0.000255	0.00409	CbGeAlD
Gemcitabine—DCK—medulla oblongata—germ cell cancer	0.000254	0.00407	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000252	0.00665	CbGpPWpGaD
Gemcitabine—ABCC10—pituitary gland—germ cell cancer	0.00025	0.00402	CbGeAlD
Gemcitabine—RRM1—testis—germ cell cancer	0.00025	0.00401	CbGeAlD
Gemcitabine—SLC29A1—adrenal gland—germ cell cancer	0.000246	0.00394	CbGeAlD
Gemcitabine—ABCC10—medulla oblongata—germ cell cancer	0.000242	0.00388	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—germ cell cancer	0.000238	0.00381	CbGeAlD
Gemcitabine—TYMS—endocrine gland—germ cell cancer	0.000238	0.00381	CbGeAlD
Gemcitabine—POLA1—brain—germ cell cancer	0.000236	0.00379	CbGeAlD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000236	0.00623	CbGpPWpGaD
Gemcitabine—POLA1—Telomere Maintenance—H2AFZ—germ cell cancer	0.000235	0.00622	CbGpPWpGaD
Gemcitabine—DCK—adrenal gland—germ cell cancer	0.000235	0.00377	CbGeAlD
Gemcitabine—TYMS—head—germ cell cancer	0.000235	0.00376	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000232	0.00613	CbGpPWpGaD
Gemcitabine—DCK—midbrain—germ cell cancer	0.000232	0.00372	CbGeAlD
Gemcitabine—RRM1—cerebellum—germ cell cancer	0.000231	0.0037	CbGeAlD
Gemcitabine—SLC29A1—female gonad—germ cell cancer	0.000229	0.00368	CbGeAlD
Gemcitabine—POLA1—lymph node—germ cell cancer	0.000228	0.00366	CbGeAlD
Gemcitabine—DCK—bone marrow—germ cell cancer	0.000227	0.00364	CbGeAlD
Gemcitabine—TYMS—testis—germ cell cancer	0.000227	0.00364	CbGeAlD
Gemcitabine—DCK—spinal cord—germ cell cancer	0.000226	0.00363	CbGeAlD
Gemcitabine—RRM2—brain—germ cell cancer	0.000226	0.00362	CbGeAlD
Gemcitabine—ABCC10—adrenal gland—germ cell cancer	0.000224	0.00359	CbGeAlD
Gemcitabine—ABCC10—midbrain—germ cell cancer	0.000221	0.00354	CbGeAlD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000221	0.00584	CbGpPWpGaD
Gemcitabine—DCK—female gonad—germ cell cancer	0.000219	0.00351	CbGeAlD
Gemcitabine—RRM2—lymph node—germ cell cancer	0.000218	0.0035	CbGeAlD
Gemcitabine—ABCC10—bone marrow—germ cell cancer	0.000216	0.00347	CbGeAlD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000216	0.0057	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000215	0.0057	CbGpPWpGaD
Gemcitabine—ABCC10—spinal cord—germ cell cancer	0.000215	0.00346	CbGeAlD
Gemcitabine—SLC29A1—endocrine gland—germ cell cancer	0.000213	0.00342	CbGeAlD
Gemcitabine—SLC29A1—head—germ cell cancer	0.00021	0.00337	CbGeAlD
Gemcitabine—TYMS—cerebellum—germ cell cancer	0.000209	0.00336	CbGeAlD
Gemcitabine—ABCC10—female gonad—germ cell cancer	0.000209	0.00335	CbGeAlD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000208	0.00551	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000206	0.00546	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000205	0.00543	CbGpPWpGaD
Gemcitabine—DCK—endocrine gland—germ cell cancer	0.000204	0.00327	CbGeAlD
Gemcitabine—SLC29A1—testis—germ cell cancer	0.000203	0.00326	CbGeAlD
Gemcitabine—DCK—head—germ cell cancer	0.000201	0.00322	CbGeAlD
Gemcitabine—POLA1—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000196	0.00518	CbGpPWpGaD
Gemcitabine—DCK—testis—germ cell cancer	0.000194	0.00311	CbGeAlD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000194	0.00513	CbGpPWpGaD
Gemcitabine—ABCC10—endocrine gland—germ cell cancer	0.000194	0.00311	CbGeAlD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000194	0.00512	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000191	0.00504	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000189	0.005	CbGpPWpGaD
Gemcitabine—SLC29A1—cerebellum—germ cell cancer	0.000188	0.00301	CbGeAlD
Gemcitabine—RRM1—brain—germ cell cancer	0.000187	0.00301	CbGeAlD
Gemcitabine—ABCC10—testis—germ cell cancer	0.000185	0.00297	CbGeAlD
Gemcitabine—ABCB1—blood vessel—germ cell cancer	0.000183	0.00294	CbGeAlD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000182	0.00481	CbGpPWpGaD
Gemcitabine—RRM1—lymph node—germ cell cancer	0.000181	0.00291	CbGeAlD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000179	0.00474	CbGpPWpGaD
Gemcitabine—DCK—cerebellum—germ cell cancer	0.000179	0.00288	CbGeAlD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000176	0.00465	CbGpPWpGaD
Gemcitabine—ABCC10—cerebellum—germ cell cancer	0.000171	0.00274	CbGeAlD
Gemcitabine—TYMS—brain—germ cell cancer	0.00017	0.00273	CbGeAlD
Gemcitabine—TYMS—lymph node—germ cell cancer	0.000164	0.00264	CbGeAlD
Gemcitabine—CMPK1—Metabolism—SLC2A3—germ cell cancer	0.000158	0.00418	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SLC22A3—germ cell cancer	0.000156	0.00411	CbGpPWpGaD
Gemcitabine—SLC29A1—brain—germ cell cancer	0.000152	0.00245	CbGeAlD
Gemcitabine—RRM1—E2F transcription factor network—MYC—germ cell cancer	0.000152	0.00402	CbGpPWpGaD
Gemcitabine—SLC29A1—lymph node—germ cell cancer	0.000147	0.00236	CbGeAlD
Gemcitabine—DCK—brain—germ cell cancer	0.000146	0.00234	CbGeAlD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000144	0.00382	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000142	0.00376	CbGpPWpGaD
Gemcitabine—DCK—lymph node—germ cell cancer	0.000141	0.00226	CbGeAlD
Gemcitabine—ABCC10—brain—germ cell cancer	0.000139	0.00223	CbGeAlD
Gemcitabine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000136	0.00107	CcSEcCtD
Gemcitabine—Anaemia—Dactinomycin—germ cell cancer	0.000136	0.00107	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000135	0.00106	CcSEcCtD
Gemcitabine—Erythema—Ifosfamide—germ cell cancer	0.000135	0.00106	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Etoposide—germ cell cancer	0.000134	0.00106	CcSEcCtD
Gemcitabine—Chest pain—Bleomycin—germ cell cancer	0.000134	0.00106	CcSEcCtD
Gemcitabine—Myalgia—Bleomycin—germ cell cancer	0.000134	0.00106	CcSEcCtD
Gemcitabine—ABCC10—lymph node—germ cell cancer	0.000134	0.00215	CbGeAlD
Gemcitabine—Renal failure—Etoposide—germ cell cancer	0.000134	0.00105	CcSEcCtD
Gemcitabine—Myocardial infarction—Etoposide—germ cell cancer	0.000133	0.00105	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Etoposide—germ cell cancer	0.000133	0.00105	CcSEcCtD
Gemcitabine—Stomatitis—Etoposide—germ cell cancer	0.000133	0.00105	CcSEcCtD
Gemcitabine—Discomfort—Bleomycin—germ cell cancer	0.000133	0.00104	CcSEcCtD
Gemcitabine—Malaise—Dactinomycin—germ cell cancer	0.000133	0.00104	CcSEcCtD
Gemcitabine—Decreased appetite—Vinblastine—germ cell cancer	0.000132	0.00104	CcSEcCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000132	0.00349	CbGpPWpGaD
Gemcitabine—Urinary tract disorder—Cisplatin—germ cell cancer	0.000132	0.00104	CcSEcCtD
Gemcitabine—Leukopenia—Dactinomycin—germ cell cancer	0.000132	0.00104	CcSEcCtD
Gemcitabine—Connective tissue disorder—Cisplatin—germ cell cancer	0.000131	0.00103	CcSEcCtD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000131	0.00346	CbGpPWpGaD
Gemcitabine—Urethral disorder—Cisplatin—germ cell cancer	0.000131	0.00103	CcSEcCtD
Gemcitabine—Pain—Vinblastine—germ cell cancer	0.00013	0.00103	CcSEcCtD
Gemcitabine—Constipation—Vinblastine—germ cell cancer	0.00013	0.00103	CcSEcCtD
Gemcitabine—Pulmonary oedema—Methotrexate—germ cell cancer	0.00013	0.00102	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Etoposide—germ cell cancer	0.000129	0.00101	CcSEcCtD
Gemcitabine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000129	0.00101	CcSEcCtD
Gemcitabine—Oedema—Bleomycin—germ cell cancer	0.000129	0.00101	CcSEcCtD
Gemcitabine—Infection—Bleomycin—germ cell cancer	0.000128	0.00101	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—MYC—germ cell cancer	0.000127	0.00336	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000127	0.00336	CbGpPWpGaD
Gemcitabine—Agranulocytosis—Etoposide—germ cell cancer	0.000127	0.001	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—CRABP1—germ cell cancer	0.000127	0.00335	CbGpPWpGaD
Gemcitabine—Sepsis—Methotrexate—germ cell cancer	0.000126	0.000996	CcSEcCtD
Gemcitabine—Thrombocytopenia—Bleomycin—germ cell cancer	0.000126	0.000992	CcSEcCtD
Gemcitabine—Feeling abnormal—Vinblastine—germ cell cancer	0.000125	0.000988	CcSEcCtD
Gemcitabine—RRM2—E2F transcription factor network—MYC—germ cell cancer	0.000125	0.00331	CbGpPWpGaD
Gemcitabine—Myalgia—Dactinomycin—germ cell cancer	0.000125	0.000986	CcSEcCtD
Gemcitabine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000125	0.000984	CcSEcCtD
Gemcitabine—Anaemia—Ifosfamide—germ cell cancer	0.000124	0.000981	CcSEcCtD
Gemcitabine—Cardiac disorder—Cisplatin—germ cell cancer	0.000124	0.000975	CcSEcCtD
Gemcitabine—Discomfort—Dactinomycin—germ cell cancer	0.000124	0.000974	CcSEcCtD
Gemcitabine—Anorexia—Bleomycin—germ cell cancer	0.000123	0.000966	CcSEcCtD
Gemcitabine—Malaise—Ifosfamide—germ cell cancer	0.000121	0.000957	CcSEcCtD
Gemcitabine—Urinary tract disorder—Etoposide—germ cell cancer	0.000121	0.000951	CcSEcCtD
Gemcitabine—Leukopenia—Ifosfamide—germ cell cancer	0.000121	0.00095	CcSEcCtD
Gemcitabine—Immune system disorder—Cisplatin—germ cell cancer	0.00012	0.000949	CcSEcCtD
Gemcitabine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00012	0.000947	CcSEcCtD
Gemcitabine—Hypotension—Bleomycin—germ cell cancer	0.00012	0.000947	CcSEcCtD
Gemcitabine—Oedema—Dactinomycin—germ cell cancer	0.00012	0.000945	CcSEcCtD
Gemcitabine—Urethral disorder—Etoposide—germ cell cancer	0.00012	0.000944	CcSEcCtD
Gemcitabine—Infection—Dactinomycin—germ cell cancer	0.000119	0.000939	CcSEcCtD
Gemcitabine—Arrhythmia—Cisplatin—germ cell cancer	0.000119	0.000939	CcSEcCtD
Gemcitabine—Alopecia—Cisplatin—germ cell cancer	0.000118	0.000928	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000118	0.00312	CbGpPWpGaD
Gemcitabine—Hepatic failure—Methotrexate—germ cell cancer	0.000118	0.000927	CcSEcCtD
Gemcitabine—Cough—Ifosfamide—germ cell cancer	0.000118	0.000926	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000117	0.000925	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000117	0.000923	CcSEcCtD
Gemcitabine—Hypertension—Ifosfamide—germ cell cancer	0.000116	0.000916	CcSEcCtD
Gemcitabine—Erythema—Cisplatin—germ cell cancer	0.000116	0.000915	CcSEcCtD
Gemcitabine—Erythema multiforme—Etoposide—germ cell cancer	0.000116	0.00091	CcSEcCtD
Gemcitabine—Paraesthesia—Bleomycin—germ cell cancer	0.000115	0.00091	CcSEcCtD
Gemcitabine—Dyspnoea—Bleomycin—germ cell cancer	0.000115	0.000903	CcSEcCtD
Gemcitabine—Arthralgia—Ifosfamide—germ cell cancer	0.000115	0.000903	CcSEcCtD
Gemcitabine—Chest pain—Ifosfamide—germ cell cancer	0.000115	0.000903	CcSEcCtD
Gemcitabine—Myalgia—Ifosfamide—germ cell cancer	0.000115	0.000903	CcSEcCtD
Gemcitabine—Anorexia—Dactinomycin—germ cell cancer	0.000114	0.000901	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000114	0.000897	CcSEcCtD
Gemcitabine—Cardiac disorder—Etoposide—germ cell cancer	0.000113	0.000893	CcSEcCtD
Gemcitabine—Discomfort—Ifosfamide—germ cell cancer	0.000113	0.000892	CcSEcCtD
Gemcitabine—ABCB1—trigeminal ganglion—germ cell cancer	0.000113	0.00181	CbGeAlD
Gemcitabine—Decreased appetite—Bleomycin—germ cell cancer	0.000112	0.000881	CcSEcCtD
Gemcitabine—Angiopathy—Etoposide—germ cell cancer	0.000111	0.000873	CcSEcCtD
Gemcitabine—Immune system disorder—Etoposide—germ cell cancer	0.00011	0.000869	CcSEcCtD
Gemcitabine—Mediastinal disorder—Etoposide—germ cell cancer	0.00011	0.000867	CcSEcCtD
Gemcitabine—Pain—Bleomycin—germ cell cancer	0.00011	0.000866	CcSEcCtD
Gemcitabine—Oedema—Ifosfamide—germ cell cancer	0.00011	0.000866	CcSEcCtD
Gemcitabine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00011	0.000866	CcSEcCtD
Gemcitabine—Chills—Etoposide—germ cell cancer	0.00011	0.000864	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000109	0.000861	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000109	0.000861	CcSEcCtD
Gemcitabine—Asthenia—Vinblastine—germ cell cancer	0.000109	0.000861	CcSEcCtD
Gemcitabine—Infection—Ifosfamide—germ cell cancer	0.000109	0.00086	CcSEcCtD
Gemcitabine—ABCB1—embryo—germ cell cancer	0.000109	0.00175	CbGeAlD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000109	0.00288	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000109	0.00287	CbGpPWpGaD
Gemcitabine—Alopecia—Etoposide—germ cell cancer	0.000108	0.000851	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000108	0.00085	CcSEcCtD
Gemcitabine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000108	0.000849	CcSEcCtD
Gemcitabine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000108	0.000849	CcSEcCtD
Gemcitabine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000108	0.000848	CcSEcCtD
Gemcitabine—Anaemia—Cisplatin—germ cell cancer	0.000107	0.000845	CcSEcCtD
Gemcitabine—Skin disorder—Ifosfamide—germ cell cancer	0.000107	0.000841	CcSEcCtD
Gemcitabine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000106	0.000837	CcSEcCtD
Gemcitabine—Feeling abnormal—Bleomycin—germ cell cancer	0.000106	0.000835	CcSEcCtD
Gemcitabine—Anorexia—Ifosfamide—germ cell cancer	0.000105	0.000825	CcSEcCtD
Gemcitabine—Malaise—Cisplatin—germ cell cancer	0.000105	0.000825	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—germ cell cancer	0.000104	0.00276	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000104	0.00276	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	0.000104	0.00276	CbGpPWpGaD
Gemcitabine—Decreased appetite—Dactinomycin—germ cell cancer	0.000104	0.000821	CcSEcCtD
Gemcitabine—Diarrhoea—Vinblastine—germ cell cancer	0.000104	0.000821	CcSEcCtD
Gemcitabine—Leukopenia—Cisplatin—germ cell cancer	0.000104	0.000819	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—germ cell cancer	0.000103	0.000815	CcSEcCtD
Gemcitabine—Back pain—Etoposide—germ cell cancer	0.000103	0.00081	CcSEcCtD
Gemcitabine—Hypotension—Ifosfamide—germ cell cancer	0.000103	0.000809	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—germ cell cancer	0.000103	0.000808	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000102	0.00269	CbGpPWpGaD
Gemcitabine—Body temperature increased—Bleomycin—germ cell cancer	0.000102	0.000801	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.0001	0.000789	CcSEcCtD
Gemcitabine—Myalgia—Cisplatin—germ cell cancer	9.89e-05	0.000779	CcSEcCtD
Gemcitabine—Feeling abnormal—Dactinomycin—germ cell cancer	9.88e-05	0.000779	CcSEcCtD
Gemcitabine—Paraesthesia—Ifosfamide—germ cell cancer	9.87e-05	0.000777	CcSEcCtD
Gemcitabine—Ill-defined disorder—Etoposide—germ cell cancer	9.87e-05	0.000777	CcSEcCtD
Gemcitabine—Anaemia—Etoposide—germ cell cancer	9.83e-05	0.000774	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	9.82e-05	0.000773	CcSEcCtD
Gemcitabine—Dyspnoea—Ifosfamide—germ cell cancer	9.8e-05	0.000772	CcSEcCtD
Gemcitabine—Somnolence—Ifosfamide—germ cell cancer	9.77e-05	0.00077	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—germ cell cancer	9.77e-05	0.000769	CcSEcCtD
Gemcitabine—Discomfort—Cisplatin—germ cell cancer	9.77e-05	0.000769	CcSEcCtD
Gemcitabine—CDA—Metabolism—SLC2A3—germ cell cancer	9.76e-05	0.00258	CbGpPWpGaD
Gemcitabine—Vomiting—Vinblastine—germ cell cancer	9.68e-05	0.000763	CcSEcCtD
Gemcitabine—ABCB1—retina—germ cell cancer	9.65e-05	0.00155	CbGeAlD
Gemcitabine—CDA—Metabolism—SLC22A3—germ cell cancer	9.61e-05	0.00254	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—AVP—germ cell cancer	9.61e-05	0.00254	CbGpPWpGaD
Gemcitabine—Malaise—Etoposide—germ cell cancer	9.59e-05	0.000756	CcSEcCtD
Gemcitabine—Decreased appetite—Ifosfamide—germ cell cancer	9.56e-05	0.000753	CcSEcCtD
Gemcitabine—Headache—Vinblastine—germ cell cancer	9.54e-05	0.000751	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	9.53e-05	0.00075	CcSEcCtD
Gemcitabine—Leukopenia—Etoposide—germ cell cancer	9.52e-05	0.00075	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—AVP—germ cell cancer	9.5e-05	0.00251	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	9.49e-05	0.000747	CcSEcCtD
Gemcitabine—Body temperature increased—Dactinomycin—germ cell cancer	9.48e-05	0.000747	CcSEcCtD
Gemcitabine—Fatigue—Ifosfamide—germ cell cancer	9.48e-05	0.000746	CcSEcCtD
Gemcitabine—Anaphylactic shock—Cisplatin—germ cell cancer	9.48e-05	0.000746	CcSEcCtD
Gemcitabine—Oedema—Cisplatin—germ cell cancer	9.48e-05	0.000746	CcSEcCtD
Gemcitabine—Infection—Cisplatin—germ cell cancer	9.41e-05	0.000742	CcSEcCtD
Gemcitabine—Pain—Ifosfamide—germ cell cancer	9.4e-05	0.00074	CcSEcCtD
Gemcitabine—Constipation—Ifosfamide—germ cell cancer	9.4e-05	0.00074	CcSEcCtD
Gemcitabine—Nervous system disorder—Cisplatin—germ cell cancer	9.29e-05	0.000732	CcSEcCtD
Gemcitabine—Cough—Etoposide—germ cell cancer	9.28e-05	0.000731	CcSEcCtD
Gemcitabine—Thrombocytopenia—Cisplatin—germ cell cancer	9.28e-05	0.000731	CcSEcCtD
Gemcitabine—Asthenia—Bleomycin—germ cell cancer	9.23e-05	0.000727	CcSEcCtD
Gemcitabine—Skin disorder—Cisplatin—germ cell cancer	9.2e-05	0.000725	CcSEcCtD
Gemcitabine—Hypertension—Etoposide—germ cell cancer	9.18e-05	0.000723	CcSEcCtD
Gemcitabine—Hyperhidrosis—Cisplatin—germ cell cancer	9.16e-05	0.000722	CcSEcCtD
Gemcitabine—Pruritus—Bleomycin—germ cell cancer	9.1e-05	0.000717	CcSEcCtD
Gemcitabine—RRM2—G1/S Transition—MYC—germ cell cancer	9.09e-05	0.0024	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Ifosfamide—germ cell cancer	9.06e-05	0.000713	CcSEcCtD
Gemcitabine—Chest pain—Etoposide—germ cell cancer	9.06e-05	0.000713	CcSEcCtD
Gemcitabine—Nausea—Vinblastine—germ cell cancer	9.05e-05	0.000712	CcSEcCtD
Gemcitabine—Anorexia—Cisplatin—germ cell cancer	9.03e-05	0.000712	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	8.99e-05	0.000708	CcSEcCtD
Gemcitabine—Discomfort—Etoposide—germ cell cancer	8.95e-05	0.000705	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	8.94e-05	0.00236	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—AVP—germ cell cancer	8.93e-05	0.00236	CbGpPWpGaD
Gemcitabine—ABCB1—telencephalon—germ cell cancer	8.88e-05	0.00142	CbGeAlD
Gemcitabine—Hypotension—Cisplatin—germ cell cancer	8.86e-05	0.000697	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—MYC—germ cell cancer	8.72e-05	0.00231	CbGpPWpGaD
Gemcitabine—Body temperature increased—Ifosfamide—germ cell cancer	8.69e-05	0.000684	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—germ cell cancer	8.68e-05	0.000684	CcSEcCtD
Gemcitabine—Anaphylactic shock—Etoposide—germ cell cancer	8.68e-05	0.000684	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.63e-05	0.00068	CcSEcCtD
Gemcitabine—Infection—Etoposide—germ cell cancer	8.62e-05	0.000679	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—germ cell cancer	8.61e-05	0.000678	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	8.58e-05	0.00227	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—MYC—germ cell cancer	8.56e-05	0.00226	CbGpPWpGaD
Gemcitabine—Neutropenia—Methotrexate—germ cell cancer	8.55e-05	0.000674	CcSEcCtD
Gemcitabine—Paraesthesia—Cisplatin—germ cell cancer	8.51e-05	0.00067	CcSEcCtD
Gemcitabine—Thrombocytopenia—Etoposide—germ cell cancer	8.5e-05	0.00067	CcSEcCtD
Gemcitabine—Dyspnoea—Cisplatin—germ cell cancer	8.45e-05	0.000665	CcSEcCtD
Gemcitabine—Skin disorder—Etoposide—germ cell cancer	8.43e-05	0.000664	CcSEcCtD
Gemcitabine—ABCB1—decidua—germ cell cancer	8.41e-05	0.00135	CbGeAlD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—AVP—germ cell cancer	8.4e-05	0.00222	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Etoposide—germ cell cancer	8.39e-05	0.000661	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	8.35e-05	0.00221	CbGpPWpGaD
Gemcitabine—Anorexia—Etoposide—germ cell cancer	8.28e-05	0.000652	CcSEcCtD
Gemcitabine—Decreased appetite—Cisplatin—germ cell cancer	8.24e-05	0.000649	CcSEcCtD
Gemcitabine—Diarrhoea—Dactinomycin—germ cell cancer	8.21e-05	0.000646	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—MYC—germ cell cancer	8.2e-05	0.00217	CbGpPWpGaD
Gemcitabine—Pneumonia—Methotrexate—germ cell cancer	8.2e-05	0.000646	CcSEcCtD
Gemcitabine—POLD1—S Phase—MYC—germ cell cancer	8.2e-05	0.00217	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Cisplatin—germ cell cancer	8.18e-05	0.000644	CcSEcCtD
Gemcitabine—Vomiting—Bleomycin—germ cell cancer	8.18e-05	0.000644	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	8.13e-05	0.00215	CbGpPWpGaD
Gemcitabine—Hypotension—Etoposide—germ cell cancer	8.11e-05	0.000639	CcSEcCtD
Gemcitabine—Rash—Bleomycin—germ cell cancer	8.11e-05	0.000639	CcSEcCtD
Gemcitabine—Pain—Cisplatin—germ cell cancer	8.1e-05	0.000638	CcSEcCtD
Gemcitabine—Dermatitis—Bleomycin—germ cell cancer	8.1e-05	0.000638	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	8.08e-05	0.000637	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	8.08e-05	0.00214	CbGpPWpGaD
Gemcitabine—Renal failure—Methotrexate—germ cell cancer	8.01e-05	0.000631	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—germ cell cancer	7.95e-05	0.000626	CcSEcCtD
Gemcitabine—POLE—S Phase—MYC—germ cell cancer	7.92e-05	0.00209	CbGpPWpGaD
Gemcitabine—Asthenia—Ifosfamide—germ cell cancer	7.89e-05	0.000621	CcSEcCtD
Gemcitabine—CDA—Metabolism—CRABP1—germ cell cancer	7.83e-05	0.00207	CbGpPWpGaD
Gemcitabine—Sweating—Methotrexate—germ cell cancer	7.82e-05	0.000616	CcSEcCtD
Gemcitabine—Feeling abnormal—Cisplatin—germ cell cancer	7.81e-05	0.000615	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	7.8e-05	0.00206	CbGpPWpGaD
Gemcitabine—Paraesthesia—Etoposide—germ cell cancer	7.8e-05	0.000614	CcSEcCtD
Gemcitabine—Pruritus—Ifosfamide—germ cell cancer	7.78e-05	0.000613	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—germ cell cancer	7.77e-05	0.000612	CcSEcCtD
Gemcitabine—Dyspnoea—Etoposide—germ cell cancer	7.74e-05	0.00061	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—germ cell cancer	7.72e-05	0.000608	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—germ cell cancer	7.71e-05	0.000607	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—germ cell cancer	7.66e-05	0.00202	CbGpPWpGaD
Gemcitabine—Nausea—Bleomycin—germ cell cancer	7.64e-05	0.000602	CcSEcCtD
Gemcitabine—Vomiting—Dactinomycin—germ cell cancer	7.63e-05	0.000601	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—germ cell cancer	7.61e-05	0.000599	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—germ cell cancer	7.56e-05	0.000596	CcSEcCtD
Gemcitabine—Decreased appetite—Etoposide—germ cell cancer	7.55e-05	0.000594	CcSEcCtD
Gemcitabine—Diarrhoea—Ifosfamide—germ cell cancer	7.52e-05	0.000592	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Etoposide—germ cell cancer	7.5e-05	0.00059	CcSEcCtD
Gemcitabine—Body temperature increased—Cisplatin—germ cell cancer	7.49e-05	0.00059	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—germ cell cancer	7.48e-05	0.00059	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	7.44e-05	0.00197	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	7.43e-05	0.00197	CbGpPWpGaD
Gemcitabine—Pain—Etoposide—germ cell cancer	7.42e-05	0.000585	CcSEcCtD
Gemcitabine—Constipation—Etoposide—germ cell cancer	7.42e-05	0.000585	CcSEcCtD
Gemcitabine—ABCB1—gonad—germ cell cancer	7.41e-05	0.00119	CbGeAlD
Gemcitabine—RRM1—Metabolism—SLC2A3—germ cell cancer	7.39e-05	0.00195	CbGpPWpGaD
Gemcitabine—ABCB1—uterus—germ cell cancer	7.36e-05	0.00118	CbGeAlD
Gemcitabine—Haemoglobin—Methotrexate—germ cell cancer	7.36e-05	0.000579	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—germ cell cancer	7.35e-05	0.00194	CbGpPWpGaD
Gemcitabine—Haemorrhage—Methotrexate—germ cell cancer	7.32e-05	0.000577	CcSEcCtD
Gemcitabine—RRM1—Metabolism—SLC22A3—germ cell cancer	7.28e-05	0.00193	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—H2AFZ—germ cell cancer	7.27e-05	0.00192	CbGpPWpGaD
Gemcitabine—Pharyngitis—Methotrexate—germ cell cancer	7.26e-05	0.000572	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—germ cell cancer	7.23e-05	0.000569	CcSEcCtD
Gemcitabine—ABCB1—pituitary gland—germ cell cancer	7.23e-05	0.00116	CbGeAlD
Gemcitabine—POLD1—Cell Cycle—H2AFZ—germ cell cancer	7.22e-05	0.00191	CbGpPWpGaD
Gemcitabine—Urethral disorder—Methotrexate—germ cell cancer	7.18e-05	0.000565	CcSEcCtD
Gemcitabine—Feeling abnormal—Etoposide—germ cell cancer	7.15e-05	0.000564	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	7.13e-05	0.00189	CbGpPWpGaD
Gemcitabine—Nausea—Dactinomycin—germ cell cancer	7.13e-05	0.000561	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.04e-05	0.00186	CbGpPWpGaD
Gemcitabine—Vomiting—Ifosfamide—germ cell cancer	6.99e-05	0.000551	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—H2AFZ—germ cell cancer	6.98e-05	0.00184	CbGpPWpGaD
Gemcitabine—ABCB1—medulla oblongata—germ cell cancer	6.97e-05	0.00112	CbGeAlD
Gemcitabine—Rash—Ifosfamide—germ cell cancer	6.93e-05	0.000546	CcSEcCtD
Gemcitabine—Dermatitis—Ifosfamide—germ cell cancer	6.92e-05	0.000545	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—germ cell cancer	6.92e-05	0.000545	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—germ cell cancer	6.86e-05	0.000541	CcSEcCtD
Gemcitabine—Asthenia—Cisplatin—germ cell cancer	6.8e-05	0.000536	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—germ cell cancer	6.79e-05	0.000535	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—AVP—germ cell cancer	6.66e-05	0.00176	CbGpPWpGaD
Gemcitabine—Angiopathy—Methotrexate—germ cell cancer	6.64e-05	0.000523	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—germ cell cancer	6.61e-05	0.000521	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—germ cell cancer	6.6e-05	0.00052	CcSEcCtD
Gemcitabine—Chills—Methotrexate—germ cell cancer	6.57e-05	0.000517	CcSEcCtD
Gemcitabine—Nausea—Ifosfamide—germ cell cancer	6.53e-05	0.000514	CcSEcCtD
Gemcitabine—Diarrhoea—Cisplatin—germ cell cancer	6.48e-05	0.000511	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—germ cell cancer	6.47e-05	0.000509	CcSEcCtD
Gemcitabine—ABCB1—adrenal gland—germ cell cancer	6.46e-05	0.00104	CbGeAlD
Gemcitabine—ABCB1—midbrain—germ cell cancer	6.37e-05	0.00102	CbGeAlD
Gemcitabine—Erythema—Methotrexate—germ cell cancer	6.37e-05	0.000502	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	6.33e-05	0.00167	CbGpPWpGaD
Gemcitabine—ABCB1—bone marrow—germ cell cancer	6.25e-05	0.001	CbGeAlD
Gemcitabine—Asthenia—Etoposide—germ cell cancer	6.23e-05	0.000491	CcSEcCtD
Gemcitabine—ABCB1—spinal cord—germ cell cancer	6.22e-05	0.000998	CbGeAlD
Gemcitabine—POLA1—G1/S Transition—MYC—germ cell cancer	6.21e-05	0.00164	CbGpPWpGaD
Gemcitabine—Back pain—Methotrexate—germ cell cancer	6.16e-05	0.000485	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—germ cell cancer	6.14e-05	0.000484	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	6.11e-05	0.00162	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC2A3—germ cell cancer	6.09e-05	0.00161	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC2A3—germ cell cancer	6.05e-05	0.0016	CbGpPWpGaD
Gemcitabine—Vomiting—Cisplatin—germ cell cancer	6.03e-05	0.000475	CcSEcCtD
Gemcitabine—ABCB1—female gonad—germ cell cancer	6.02e-05	0.000966	CbGeAlD
Gemcitabine—RRM2—Metabolism—SLC22A3—germ cell cancer	6e-05	0.00159	CbGpPWpGaD
Gemcitabine—Rash—Cisplatin—germ cell cancer	5.98e-05	0.000471	CcSEcCtD
Gemcitabine—Dermatitis—Cisplatin—germ cell cancer	5.97e-05	0.00047	CcSEcCtD
Gemcitabine—POLD1—Metabolism—SLC22A3—germ cell cancer	5.96e-05	0.00158	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—MYC—germ cell cancer	5.95e-05	0.00157	CbGpPWpGaD
Gemcitabine—Diarrhoea—Etoposide—germ cell cancer	5.94e-05	0.000468	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CRABP1—germ cell cancer	5.94e-05	0.00157	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Methotrexate—germ cell cancer	5.91e-05	0.000466	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—germ cell cancer	5.89e-05	0.000464	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	5.86e-05	0.00155	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.78e-05	0.00153	CbGpPWpGaD
Gemcitabine—Malaise—Methotrexate—germ cell cancer	5.75e-05	0.000453	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—germ cell cancer	5.7e-05	0.000449	CcSEcCtD
Gemcitabine—DCK—Metabolism—SLC2A3—germ cell cancer	5.69e-05	0.0015	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—germ cell cancer	5.64e-05	0.00149	CbGpPWpGaD
Gemcitabine—Nausea—Cisplatin—germ cell cancer	5.63e-05	0.000443	CcSEcCtD
Gemcitabine—DCK—Metabolism—SLC22A3—germ cell cancer	5.6e-05	0.00148	CbGpPWpGaD
Gemcitabine—ABCB1—endocrine gland—germ cell cancer	5.6e-05	0.000898	CbGeAlD
Gemcitabine—POLA1—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	5.56e-05	0.00147	CbGpPWpGaD
Gemcitabine—Cough—Methotrexate—germ cell cancer	5.56e-05	0.000438	CcSEcCtD
Gemcitabine—ABCB1—head—germ cell cancer	5.53e-05	0.000887	CbGeAlD
Gemcitabine—Vomiting—Etoposide—germ cell cancer	5.52e-05	0.000435	CcSEcCtD
Gemcitabine—Rash—Etoposide—germ cell cancer	5.47e-05	0.000431	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—germ cell cancer	5.47e-05	0.000431	CcSEcCtD
Gemcitabine—Headache—Etoposide—germ cell cancer	5.44e-05	0.000428	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—germ cell cancer	5.42e-05	0.000427	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—germ cell cancer	5.42e-05	0.000427	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—germ cell cancer	5.42e-05	0.000427	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.39e-05	0.000424	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—germ cell cancer	5.36e-05	0.000422	CcSEcCtD
Gemcitabine—ABCB1—testis—germ cell cancer	5.34e-05	0.000857	CbGeAlD
Gemcitabine—TYMS—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	5.33e-05	0.00141	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—germ cell cancer	5.24e-05	0.00138	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Methotrexate—germ cell cancer	5.2e-05	0.00041	CcSEcCtD
Gemcitabine—Infection—Methotrexate—germ cell cancer	5.17e-05	0.000407	CcSEcCtD
Gemcitabine—Nausea—Etoposide—germ cell cancer	5.16e-05	0.000406	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—germ cell cancer	5.1e-05	0.000402	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—germ cell cancer	5.09e-05	0.000401	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—germ cell cancer	5.05e-05	0.000398	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—germ cell cancer	5.03e-05	0.000396	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—germ cell cancer	5.02e-05	0.00133	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—H2AFZ—germ cell cancer	4.97e-05	0.00131	CbGpPWpGaD
Gemcitabine—Anorexia—Methotrexate—germ cell cancer	4.96e-05	0.00039	CcSEcCtD
Gemcitabine—ABCB1—cerebellum—germ cell cancer	4.93e-05	0.000791	CbGeAlD
Gemcitabine—RRM2—Metabolism—CRABP1—germ cell cancer	4.89e-05	0.00129	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CRABP1—germ cell cancer	4.86e-05	0.00128	CbGpPWpGaD
Gemcitabine—Hypotension—Methotrexate—germ cell cancer	4.86e-05	0.000383	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—H2AFZ—germ cell cancer	4.76e-05	0.00126	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.74e-05	0.000373	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—germ cell cancer	4.7e-05	0.00037	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—germ cell cancer	4.67e-05	0.000368	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—germ cell cancer	4.64e-05	0.000365	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—germ cell cancer	4.62e-05	0.000364	CcSEcCtD
Gemcitabine—DCK—Metabolism—CRABP1—germ cell cancer	4.57e-05	0.00121	CbGpPWpGaD
Gemcitabine—Decreased appetite—Methotrexate—germ cell cancer	4.52e-05	0.000356	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.49e-05	0.000354	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—germ cell cancer	4.48e-05	0.000353	CcSEcCtD
Gemcitabine—Pain—Methotrexate—germ cell cancer	4.45e-05	0.00035	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—germ cell cancer	4.29e-05	0.000338	CcSEcCtD
Gemcitabine—Body temperature increased—Methotrexate—germ cell cancer	4.11e-05	0.000324	CcSEcCtD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.02e-05	0.00106	CbGpPWpGaD
Gemcitabine—ABCB1—brain—germ cell cancer	4.01e-05	0.000643	CbGeAlD
Gemcitabine—TYMS—Metabolism—SLC2A3—germ cell cancer	3.99e-05	0.00105	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.97e-05	0.00105	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC22A3—germ cell cancer	3.93e-05	0.00104	CbGpPWpGaD
Gemcitabine—ABCB1—lymph node—germ cell cancer	3.87e-05	0.000621	CbGeAlD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.8e-05	0.00101	CbGpPWpGaD
Gemcitabine—Asthenia—Methotrexate—germ cell cancer	3.73e-05	0.000294	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—germ cell cancer	3.68e-05	0.00029	CcSEcCtD
Gemcitabine—Diarrhoea—Methotrexate—germ cell cancer	3.56e-05	0.00028	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.48e-05	0.000921	CbGpPWpGaD
Gemcitabine—Vomiting—Methotrexate—germ cell cancer	3.31e-05	0.00026	CcSEcCtD
Gemcitabine—Rash—Methotrexate—germ cell cancer	3.28e-05	0.000258	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—germ cell cancer	3.28e-05	0.000258	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.26e-05	0.000861	CbGpPWpGaD
Gemcitabine—Headache—Methotrexate—germ cell cancer	3.26e-05	0.000257	CcSEcCtD
Gemcitabine—TYMS—Metabolism—CRABP1—germ cell cancer	3.2e-05	0.000847	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.12e-05	0.000825	CbGpPWpGaD
Gemcitabine—Nausea—Methotrexate—germ cell cancer	3.09e-05	0.000243	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—germ cell cancer	3e-05	0.000792	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—germ cell cancer	2.81e-05	0.000742	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—germ cell cancer	2.79e-05	0.000738	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—germ cell cancer	2.7e-05	0.000713	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.63e-05	0.000695	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.59e-05	0.000685	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—germ cell cancer	2.51e-05	0.000664	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—germ cell cancer	2.5e-05	0.00066	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—germ cell cancer	2.41e-05	0.000637	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—germ cell cancer	2.06e-05	0.000545	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—germ cell cancer	2.05e-05	0.000542	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—germ cell cancer	1.98e-05	0.000523	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—germ cell cancer	1.92e-05	0.000508	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—germ cell cancer	1.84e-05	0.000487	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—germ cell cancer	1.72e-05	0.000454	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—germ cell cancer	1.65e-05	0.000435	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—germ cell cancer	1.41e-05	0.000373	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—germ cell cancer	1.35e-05	0.000357	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.23e-05	0.000326	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.21e-05	0.000321	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.21e-05	0.000321	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.17e-05	0.00031	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CRABP1—germ cell cancer	9.89e-06	0.000261	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	9.63e-06	0.000255	CbGpPWpGaD
